CRO Confidential Information Sample Clauses

CRO Confidential Information. Institution shall keep strictly confidential any information disclosed to it by Sponsor and/or CRO regarding Sponsor’s and/or CRO’s processes, pricing, systems and procedures and shall ensure that Investigator complies with the aforementioned. Institution shall protect such confidential information of Sponsor and/or CRO with the same degree of care as Institution would protect its own confidential information. Institution shall require all Study Team Members working on this Study including the assigned Investigator to comply with the terms of this provision.
AutoNDA by SimpleDocs
CRO Confidential Information. Institution shall keep strictly confidential any information disclosed to it by Sponsor and/or CRO regarding Sponsor’s and/or CRO’s processes, pricing, systems and procedures. Institution shall protect such confidential information of Sponsor and/or CRO with the same degree of care as Institution would protect its own confidential information, which degree of care shall be no less than commercially reasonable. Institution shall require all Study Team Members working on this Study to comply with the terms of this provision. Důvěrné informace CRO. Zdravotnické zařízení bude uchovávat v přísné důvěrnosti jakékoli informace, které mu budou poskytnuty Zadavatelem a/nebo CRO ohledně procesů, tvorby cen, systémů a postupů Zadavatele a/nebo CRO. Zdravotnické zařízení bude chránit takové důvěrné informace Zadavatele a/nebo CRO se stejnou mírou péče, jako by chránilo své vlastní důvěrné informace a v žádném případě ne xx xxxxx xxxxxx, xxx je komerčně přiměřené. Zdravotnické zařízení požádá všechny členy studijního týmu, aby dodržovali podmínky tohoto ustanovení.
CRO Confidential Information. Institution and Investigator shall keep strictly confidential any information disclosed to it by Sponsor and/or CRO regarding Sponsor’s and/or CRO’s processes, pricing, systems and procedures. Institution and Investigator shall protect such confidential information of Sponsor and/or CRO with the same degree of care as Institution and Investigator would protect their own confidential information, which degree of care shall be no less than commercially reasonable. Institution and Investigator shall require all Study Team Members working on this Study to comply with the terms of this provision. Důvěrné informace CRO. Poskytovatel zdravotních služeb a Zkoušející budou uchovávat v přísné důvěrnosti jakékoli informace, které jim budou poskytnuty Zadavatelem a/nebo CRO ohledně procesů, tvorby cen, systémů a postupů Zadavatele a/nebo CRO. Poskytovatel zdravotních služeb a Zkoušející budou chránit takové důvěrné informace Zadavatele a/nebo CRO se stejnou mírou péče, jako by chránili své vlastní důvěrné informace a v žádném případě ne xx xxxxx xxxxxx, xxx je komerčně přiměřené. Poskytovatel zdravotních služeb a Zkoušející požádají všechny členy studijního týmu, aby dodržovali podmínky tohoto ustanovení.
CRO Confidential Information. Institution and Investigator shall keep strictly confidential any information disclosed to it by Sponsor and/or CRO regarding Sponsor’s and/or CRO’s processes, pricing, systems and procedures. Institution and Investigator shall protect such confidential information of Sponsor and/or CRO with the same degree of care as Institution and Investigator would protect their own confidential information. Institution and Investigator shall require all Study personnel working on this Study to comply with the terms of this provision. The SPONSOR undertakes to maintain confidentiality about all facts that it has learned or learns about the Institution in connection with this Agreement or the conduct of the Study that are not publicly accessible. SPONSOR undertakes to maintain confidentiality even about facts that the Institution designates as classified and confidential. SPONSOR is also obliged to maintain confidentiality about facts of such a nature that they may cause harm to the Institution if published, regardless of whether they are of the nature of personal, business or other information.

Related to CRO Confidential Information

  • E4 Confidential Information Except to the extent set out in this clause or where disclosure is expressly permitted elsewhere in this Contract, each Party shall:

  • Prime Confidential Information The following shall constitute Confidential Information of the Contractor and should not be disclosed to third (3rd) parties: the deliverables, discoveries, ideas, concepts, software [in various stages of development], designs, drawings, specifications, techniques, models, data, source code, source files, object code, documentation, diagrams, flow charts, research, development, processes, procedures, “know-how”, marketing techniques and materials, marketing and development plans, customer names and other information related to customers, price lists, pricing policies and financial information, this Agreement and the existence of this Agreement, the relationship between the Contractor and Subcontractor, and any details of the Service under this Agreement. Subcontractor agrees not to use or reference the Contractor and/or their names, likenesses, or logos (“Identity”). Subcontractor will not use or reference Contractor or their Identity, directly or indirectly, in conjunction with any other third (3rd) parties.

  • Non-Confidential Information The term “Confidential Information” shall not include any information which: (i) is in the public domain at the time of disclosure or enters the public domain following disclosure through no fault of the receiving Party, (ii) the receiving Party, through competent evidence, can demonstrate knowledge prior to disclosure, (iii) is disclosed to the receiving Party by a third party legally entitled to make such disclosure without violation of any obligation of confidentiality or (iv) is independently developed by the receiving Party without reference to the disclosing Party’s Confidential Information as evidenced by the written records of the receiving Party.

  • Maintaining Confidential Information Executive reaffirms his obligations under the Confidentiality Agreement. Executive acknowledges and agrees that the payments provided in Section 3 above shall be subject to Executive’s continued compliance with Executive’s obligations under the Confidentiality Agreement.

  • Trade Secrets and Confidential Information (i) Executive represents and warrants that Executive (A) is not subject to any legal or contractual duty or agreement that would prevent or prohibit Executive from performing the duties contemplated by this Agreement or otherwise complying with this Agreement, and (B) is not in breach of any legal or contractual duty or agreement, including any agreement concerning trade secrets or confidential information owned by any other party. (ii) Executive agrees that Executive will not (A) use, disclose or reverse engineer Trade Secrets or Confidential Information for any purpose other than the Company’s Business, except as authorized in writing by the Company; (B) during Executive’s employment with the Company, use, disclose or reverse engineer (1) any confidential information or trade secrets of any former employer or third party or (2) any works of authorship developed in whole or in part by Executive during any former employment or for any other party, unless authorized in writing by the former employer or third party; or (C) upon Executive’s resignation or termination with the Company (1) retain Trade Secrets or Confidential Information, including any copies existing in any form (including electronic form), which are in Executive’s possession or control or (2) destroy, delete or alter Trade Secrets or Confidential Information without the Company’s prior written consent. (iii) The obligations under this Section 8 shall remain in effect as long as Trade Secrets and Confidential Information constitute trade secrets or confidential information under applicable law. The confidentiality, property and proprietary rights protections available in this Agreement are in addition to, and not exclusive of, any and all other rights to which the Company is entitled under federal and state law, including, but not limited to, rights provided under copyright laws, trade secret and confidential information laws and laws concerning fiduciary duties.

  • Other Confidential Information The Parties agree that the confidentiality provisions under this Article Nineteen are separate from, and shall not impair or modify any other confidentiality agreements that may be in place between the Parties or their Affiliates; provided however, that the confidentiality provisions of this Article Nineteen shall govern confidential treatment of all non-public information exchanged between the Parties related directly or indirectly to this Agreement as of and after the Execution Date.

  • Company Confidential Information The Subscriber acknowledges that the Company is engaged in business development including programs of research and development and the marketing of products and services. The Subscriber also recognizes the importance of protecting the Company’s trade secrets, confidential information and other proprietary information and related rights acquired through such Company’s expenditure of time, effort and money. Therefore, in consideration of the Company permitting the Subscriber to submit this subscription and have access to the Company’s information and/or Company’s confidential information otherwise coming to the Subscriber, the Subscriber agrees to be bound by the following terms and conditions with respect to the Company:

  • Access to Confidential Information Each party acknowledges that the other party, its employees or agents, may be given access to Confidential Information relating to the other parties' business or the operation of this Agreement or any negotiations relating to this Agreement.

  • Proprietary and Confidential Information The Distributor agrees on behalf of itself and its managers, officers, and employees to treat confidentially and as proprietary information of the Trust, all records and other information relative to the Trust and prior, present or potential shareholders of the Trust (and clients of said shareholders), and not to use such records and information for any purpose other than the performance of its responsibilities and duties hereunder, except (i) after prior notification to and approval in writing by the Trust, which approval shall not be unreasonably withheld and may not be withheld where the Distributor may be exposed to civil or criminal contempt proceedings for failure to comply, (ii) when requested to divulge such information by duly constituted authorities, or (iii) when so requested by the Trust. Records and other information which have become known to the public through no wrongful act of the Distributor or any of its employees, agents or representatives, and information that was already in the possession of the Distributor prior to receipt thereof from the Trust or its agent, shall not be subject to this paragraph. Further, the Distributor will adhere to the privacy policies adopted by the Trust pursuant to Title V of the Gxxxx-Xxxxx-Xxxxxx Act, as may be modified from time to time. In this regard, the Distributor shall have in place and maintain physical, electronic and procedural safeguards reasonably designed to protect the security, confidentiality and integrity of, and to prevent unauthorized access to or use of, records and information relating to the Trust and its shareholders.

  • Disclosure of Confidential Information Any Finance Party may disclose: (a) to any of its Affiliates and Related Funds and any of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives such Confidential Information as that Finance Party shall consider appropriate if any person to whom the Confidential Information is to be given pursuant to this paragraph (a) is informed in writing of its confidential nature and that some or all of such Confidential Information may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to the Confidential Information; (b) to any person: (i) to (or through) whom it assigns or transfers (or may potentially assign or transfer) all or any of its rights and/or obligations under one or more Finance Documents and to any of that person’s Affiliates, Related Funds, Representatives and professional advisers; (ii) with (or through) whom it enters into (or may potentially enter into), whether directly or indirectly, any sub-participation in relation to, or any other transaction under which payments are to be made or may be made by reference to, one or more Finance Documents and/or one or more Obligors and to any of that person’s Affiliates, Related Funds, Representatives and professional advisers; (iii) appointed by any Finance Party or by a person to whom paragraph (b)(i) or (ii) above applies to receive communications, notices, information or documents delivered pursuant to the Finance Documents on its behalf (including, without limitation, any person appointed under paragraph (c) of Clause 25.14 (Relationship with the Lenders)); (iv) who invests in or otherwise finances (or may potentially invest in or otherwise finance), directly or indirectly, any transaction referred to in paragraph (b)(i) or (b)(ii) above;

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!